Navigation Links
Dual treatment for stroke leads to improved recovery rates, reduced mortality
Date:11/12/2008

MINNAPOLIS / ST. PAUL (Nov. 12, 2008) It appears that stroke patients who receive both intravenous thrombolysis a minimally invasive treatment that dissolves abnormal blood clots and endovascular interventions such as drugs and implanting medical devices are much more likely to recover and have lower chances of dying, according to new research by the Zeenat Qureshi Stroke Research Center at the University of Minnesota Medical School.

Between 2003 and 2006, 33 consecutive patients with acute ischemic stroke which occurs when a blood clot blocks an artery in the brain were treated with thrombolysis in combination with endovascular interventions, which includes low doses of clot-fighting drugs and medical procedures such as angioplasty. The study looked at the outcomes of consecutive patients from a tertiary stroke facility where endovascular treatment was routinely available for patients treated with intravenous thromboysis. Outcomes were compared with a control cohort of 30 consecutive patients treated with thrombolysis at a comparable facility where endovascular interventions were not available.

Researchers found that the group that received both therapies experienced significantly lower mortality at 90 days (about 12 percent compared with 40 percent) with a significantly greater improvement in neurological ability by the time of discharge or follow-up. Patients younger than 80 years old showed the greatest improvement, with significant improvement in neurological deficits prior to treatment at the time of stroke.

The results were published in a recent issue of the American Journal of Neuroradiology.

"In theory it made sense to administer both treatments, but this is the first time we have the data to support the therapeutic benefit of such an approach," said Adnan I. Qureshi, M.D., executive director of the Stoke Initiative and Center at the University of Minnesota. "This is objective data to support the benefit of combination of intravenous thrombolysis and endovascular treatments."

Since the introduction of thrombolysis in the mid-1990s to clinical practice, no other treatment has been proved to further improve the clinical outcomes in patients with ischemic stroke which is why this study is important, Qureshi said.

Since both thrombolysis and additional endovascular treatments are not available at all medical centers, Qureshi said the bigger implications of this study support the creation of specialized stroke centers or designated stoke hospitals for patients who have suffered a stoke so they can receive better care.


'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Related medicine news :

1. Idea to Arm Cancer Patients with Information Specific to Their Disease and Treatment Receives Nod, Grant from American Cancer Society
2. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
3. Dental Implants Effective for Orthodontic Treatment
4. Heart Failure Patients With Normal Left Ventricular Ejection Fraction Dont Benefit From Treatment With Angiotensin II Receptor Blocker
5. Bone cancer treatment ineffective, despite promising laboratory data
6. Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
7. Researchers find predictive tests and early treatment delay progression of blood cell cancer
8. New Treatment Options for Seasonal Affective Disorder, from Harvard Mental Health Letter
9. Game Ready(TM) Announces New Hand Treatment
10. Northwestern Medical Faculty Foundation Signs Long-Term Agreement to be the Provider of Doctors for Northern Illinois Proton Treatment and Research Center
11. How women can improve their quality of life after breast cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial ... treatment. Dr. Stong is double board certified and the only facial plastic surgeon ... of hair loss. Non-surgical therapies such as stem cells can be used to provide ...
(Date:5/5/2016)... ... May 05, 2016 , ... In honor of National Nurses ... people all over the United States to thank a nurse who's made a difference ... donate $5 to the American Red Cross of San Diego/Imperial Counties (up to $10,000) ...
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a silent, ... can weaken the immune system and increase inflammation, both of which raise the risk ... adult congenital heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can ...
(Date:5/5/2016)... N.J. (PRWEB) , ... May 05, 2016 , ... ... patients with cancer, today announced a new collaboration with Imerman Angels to ... cancer anywhere in the world. , “Imerman Angels provides an emotional lifeline to patients ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dermatologic surgeons performed nearly 10 million ... up 27 percent since 2012. , The results of the 2015 ASDS Survey on ... in skin cancer treatments and the growing popularity of soft-tissue fillers and body sculpting ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016  Compass Diversified Holdings (NYSE: CODI ... of leading middle market businesses, announced today its consolidated ... 2016. First Quarter 2016 Highlights , ... or "Cash Flow") of $13.6 million for the first ... $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology: